TRCT
VTAK icon

Tower Research Capital (TRC)’s Catheter Precision VTAK Stock Holding History

Tower Research Capital (TRC)’s Portfolio VTAK Stock Details VTAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.03K Buy
9,452
+5,558
+143% +$5.28K ﹤0.01% 4101
2026
Q1 		$3.93K Buy
3,894
+515
+15% +$873 ﹤0.01% 4248
2025
Q4 		$6.18K Buy
+3,379
New +$7.77K ﹤0.01% 4075
2025
Q3 		– Sell
-324
Closed -$1.49K – 5671
2025
Q2 		$1.49K Hold
324
– – ﹤0.01% 4805
2025
Q1 		$2.12K Hold
324
– – ﹤0.01% 4588
2024
Q4 		$2.77K Buy
324
+71
+28% +$608 ﹤0.01% 4776
2024
Q3 		$1.9K Buy
253
+211
+502% +$6.78K ﹤0.01% 5085
2024
Q2 		$4.64K Buy
42
+1
+2% +$102 ﹤0.01% 4756
2024
Q1 		$3.78K Buy
41
+1
+3% +$89 ﹤0.01% 4798
2023
Q4 		$3.06K Hold
40
– – ﹤0.01% 5132
2023
Q3 		$3.35K Buy
40
+13
+48% +$1.51K ﹤0.01% 5018
2023
Q2 		$4.73K Hold
27
– – ﹤0.01% 4908
2023
Q1 		$8K Buy
27
+18
+200% +$9.78K ﹤0.01% 4674
2022
Q4 		$10K Buy
+9
New +$7.46K ﹤0.01% 4092
2022
Q3 		– Sell
-2
Closed -$7K – 6533
2022
Q2 		$7K Buy
+2
New +$6.18K ﹤0.01% 4833
2022
Q1 		– Hold
0
– – – 5866
2021
Q4 		– Hold
0
– – – 5198
2021
Q3 		– Hold
0
– – – 5006
2021
Q2 		– Hold
0
– -$1K – 5878
2021
Q1 		– Hold
0
– – – 5223
2020
Q4 		– Hold
0
– – – 4733
2020
Q3 		– Hold
0
– – – 4446
2020
Q2 		– Hold
0
– – – 3835
2019
Q2 		– Hold
0
– -$1K – 4361
2019
Q1 		– Hold
0
– – – 3641

Other funds holding VTAK

VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PUI
Purpose Unlimited Inc Toronto $2.62B AUM
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Tower Research Capital (TRC)'s VTAK Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Catheter Precision (VTAK) stake by 143% in Q2 2026, buying an estimated $5.28K and bringing the position to 9,452 shares worth $8.03K. The position accounts for ﹤0.01% of the portfolio, ranked #4101.

Tower Research Capital (TRC) first reported a position in VTAK in Q2 2022 and has held it in 15 quarters since. The position peaked at $10K in Q4 2022. 10 funds tracked by Wall St. Rank hold VTAK as of Q2 2026.

  • Tower Research Capital (TRC) held 9,452 shares of Catheter Precision worth $8.03K as of Q2 2026.
  • Tower Research Capital (TRC) bought 5,558 Catheter Precision shares in Q2 2026, an estimated $5.28K.
  • Catheter Precision made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4101 holding.
  • Tower Research Capital (TRC) first reported a position in Catheter Precision in Q2 2022 and has held it in 15 quarters since.
  • Tower Research Capital (TRC)'s Catheter Precision position peaked at $10K in Q4 2022.
  • 10 funds tracked by Wall St. Rank held Catheter Precision as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.